Related Experiment Video

Updated: Jun 22, 2026

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
07:02

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

Published on: September 9, 2020

Midterm results of passive containment surgery using the acorn Cor Cap cardiac support device in dilated

Fredrik Bredin1, Anders Franco-Cereceda

  • 1Section of Cardiothoracic Surgery & Anesthesiology, Institution of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. fredrik.bredin@karolinska.se

Journal of Cardiac Surgery
|June 23, 2009
PubMed

Insights

Passive containment surgery using the CorCap cardiac support device (CSD) safely improves cardiac function and quality of life in dilated cardiomyopathy patients. The treatment showed no significant differences between ischemic and idiopathic disease types.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Biomedical Engineering

Background:

  • Dilated cardiomyopathy (DCM) is a significant cause of heart failure.
  • Current treatments for DCM have limitations.
  • Passive containment surgery offers a novel therapeutic approach.

Purpose of the Study:

  • To assess the effects of CorCap cardiac support device (CSD) surgery on echocardiographic parameters, functional capacity, and quality of life in DCM patients.
  • To compare outcomes in patients with ischemic versus idiopathic DCM.

Main Methods:

  • Twenty DCM patients (10 ischemic, 10 idiopathic) underwent CSD implantation.
  • Preoperative and follow-up assessments included cardiac dimensions, function, functional capacity, and quality of life.
  • Mean follow-up duration was 32 ± 5 months.

Main Results:

  • CSD implantation was associated with a significant reduction in cardiac dimensions.
  • Patients demonstrated improved functional capacity and enhanced quality of life post-surgery.
  • No significant differences in outcomes were observed between ischemic and idiopathic DCM groups.

Conclusions:

  • CSD application is a safe and straightforward procedure for DCM patients.
  • The device demonstrated positive effects on cardiac dimensions, function, and quality of life.
  • Further research is warranted to optimize patient selection, surgical timing, and evaluate long-term efficacy.
Abstract

More Related Videos

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...